EFX vs FBLG · P/E 54, rev $3.35B vs $24.0M cap
Equifax Inc (EFX) versus FibroBiologics, Inc. Common Stock (FBLG) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
FibroBiologics, Inc. Common Stock (FBLG) is a biotechnology company listed on US.
Latest reported EFX revenue for 2026-06-30 was $3.35B. Net income was $355.4M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
FBLG does not have a complete income-statement cache yet.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. FBLG currently screens at market cap $24.0M.
Not investment advice. Open the EFX and FBLG stock pages for the full models.
Not investment advice.